Pasithea Therapeutics Warrants
KTTAW
5 hedge funds and large institutions have $29.9K invested in Pasithea Therapeutics Warrants in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
127% more capital invested
Capital invested by funds: $13.2K → $29.9K (+$16.7K)
1.39% more ownership
Funds ownership: 6.59% → 7.98% (+1.4%)
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$300 |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1K |
| 2 |
CS
Clear Street
New York
|
-$1 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $18K | – | – | – |
|
|
KC
2
Kepos Capital
New York
| $6K | – | – | – |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $5.22K | – | – | – |
|
|
MG
4
Marex Group
London,
| $450 | +$300 | +25,000 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $236 | +$3 | +278 | +2% |
|
|
VF
6
Virtu Financial
New York
| – | -$1K | -85,713 | Closed |
|
|
CS
7
Clear Street
New York
| – | -$1 | -100 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$1 | -100 | Closed |
|
KTTAW Hedge Fund Activity: Q4 2023 in Review
5 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pasithea Therapeutics Warrants (KTTAW) for Q4 2023, worth a combined $29.9K — up 127% from $13.2K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of KTTAW and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Marex Group, opening a new position worth an estimated $300. The largest seller was Virtu Financial, exiting entirely with an estimated $1K sold.
- 5 institutional investors held Pasithea Therapeutics Warrants (KTTAW) as of Q4 2023, down from 7 in Q3 2023.
- Funds reported $29.9K of Pasithea Therapeutics Warrants stock for Q4 2023, up 127% quarter-over-quarter.
- 1 fund opened new Pasithea Therapeutics Warrants positions in Q4 2023 and 3 closed out, a net change of -2 holders.
- The largest Pasithea Therapeutics Warrants buyer in Q4 2023 was Marex Group, an estimated $300 added.
- The largest Pasithea Therapeutics Warrants seller in Q4 2023 was Virtu Financial, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2023.